How common is pachychoroid?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prevalence of Pachychoroid

Pachychoroid features are remarkably common, affecting approximately 61% of fellow eyes in patients with unilateral central serous chorioretinopathy (CSC), with an additional 30.8% showing uncomplicated pachychoroid changes. 1

Population-Specific Prevalence Data

The most robust prevalence data comes from a large retrospective study of 536 patients with CSC, which provides the clearest window into pachychoroid frequency 1:

  • In unilateral CSC patients (282 patients): 1

    • 61% had pachychoroid pigment epitheliopathy (PPE) in the fellow eye
    • 30.8% had uncomplicated pachychoroid (UCP)
    • Only 8.2% had completely normal fellow eyes
  • Bilateral CSC occurred in 47.4% of all CSC patients, suggesting widespread pachychoroid substrate 1

  • Male predominance is notable, with a female to male ratio of 1:2.8 in CSC patients, which reflects the underlying pachychoroid population 1

Clinical Spectrum Considerations

The true prevalence of pachychoroid is likely underestimated because it represents a disease spectrum rather than a single entity 2, 3. The spectrum includes multiple phenotypes that may not always be clinically apparent 4:

  • Central serous chorioretinopathy (most commonly recognized)
  • Pachychoroid pigment epitheliopathy
  • Pachychoroid neovasculopathy
  • Polypoidal choroidal vasculopathy
  • Peripapillary pachychoroid syndrome
  • Focal choroidal excavation

The presence of pachyvessels (dilated Haller's layer vessels) is the defining feature, not necessarily increased choroidal thickness, which means pachychoroid can exist even with normal subfoveal choroidal thickness measurements 4, 5.

Age and Bilateral Disease Patterns

Bilateral pachychoroid manifestations increase with age, particularly in patients over 50 years 6:

  • 50% prevalence of bilateral CSC in patients ≥50 years old
  • 28% prevalence in patients <50 years old
  • Up to 84% bilateral disease activity in severe chronic CSC phenotypes 6

Important Clinical Pitfalls

Do not assume normal choroidal thickness excludes pachychoroid disease 4, 5. The pathognomonic finding is the presence of dilated choroidal vessels (pachyvessels) with overlying choriocapillaris attenuation, which can occur regardless of absolute choroidal thickness 5.

The 61% prevalence of PPE in fellow eyes means that when you diagnose unilateral CSC, you should actively look for subclinical pachychoroid changes in the apparently normal fellow eye 1. These eyes show characteristic RPE bumps (77.3% of PPE eyes) and pigment epithelial detachments (43% of PPE eyes) on careful OCT examination 1.

There were no significant demographic differences between patients with PPE, uncomplicated pachychoroid, and normal eyes regarding age, disease duration, sex, hypertension, steroid use, or refractive error 1, suggesting pachychoroid represents an intrinsic choroidal phenotype rather than an acquired condition from specific risk factors.

References

Research

Pachychoroid Spectrum Disorders: An Updated Review.

Journal of ophthalmic & vision research, 2023

Guideline

Pachychoroid Disease Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pachychoroid: current concepts on clinical features and pathogenesis.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.